ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Nutrition and Supplements
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 154789" data-attributes="member: 13851"><p><strong><span style="color: rgb(184, 49, 47)">Abstract:</span> Nitric oxide (NO) is a well-known vasodilator produced by the vascular endothelium via the enzyme endothelial nitric oxide synthase (eNOS). <span style="color: rgb(184, 49, 47)">The inadequate production of NO has been linked to elevated blood pressure (BP) in both human and animal studies, and might be due to substrate inaccessibility. </span>This review aimed to investigate whether oral administration of the amino acids l-arginine (Arg) and l-citrulline (Cit), which are potential substrates for eNOS, could effectively reduce BP by increasing NO production. <span style="color: rgb(26, 188, 156)">Both Arg and Cit are effective at increasing plasma Arg. Cit is approximately twice as potent, which is most likely due to a lower first-pass metabolism. The current data suggest that oral Arg supplementation can lower BP by 5.39/2.66 mmHg, which is an effect that is comparable with diet changes and exercise implementation. </span><span style="color: rgb(44, 130, 201)">The antihypertensive properties of Cit are more questionable, but are likely in the range of 4.1/2.08 to 7.54/3.77 mmHg.</span> <span style="color: rgb(184, 49, 47)">The exact mechanism by which Cit and Arg exert their effect is not fully understood, as normal plasma Arg concentration greatly exceeds the Michaelis constant (Km) of eNOS. Thus, elevated plasma Arg concentrations would not be expected to increase endogenous NO production significantly, but have nonetheless been observed in other studies. This phenomenon is known as the “l-arginine paradox”. </span></strong></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">5.</span> Conclusions and Outlook </strong></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Endothelium-dependent vasodilation via NO is essential for cardiovascular regulation in normal human physiology. </span>Dysfunction of the NO pathway occurs via several mechanisms, including substrate unavailability, and has been investigated as a potential pharmacological target. <span style="color: rgb(184, 49, 47)">The administration of NO precursors in the form of Arg have shown promising results with less convincing results for Cit, despite its theoretically advantageous pharmacokinetic properties.</span></strong> <strong>Their ease of administration and sparse adverse effects makes them great candidates in the first-line treatment of borderline or mild hypertension in addition to lifestyle changes, but more research is needed to determine their efficacy and safety as antihypertensive compounds. </strong></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Current evidence suggests a BP-lowering effect of Cit and Arg, but more research is needed to solve the “l-arginine paradox” and understand the exact mechanism by which this occurs.</span></strong> <strong>The BP-lowering effect found in the above-presented meta-analyses for both Arg and Cit is based on several small trials with heterogenic study populations regarding baseline BP and comorbidity, in which highly variable intervention durations and dosages were used. More research with larger study populations is needed to confirm these observed effects, establish optimal dosing regiments, and identify possible adverse effects. Furthermore, it would be interesting to identity possible effect modifiers, such as age, gender, comorbidity, and baseline BP, with the latter already demonstrated [49]. This knowledge would be a valuable tool for both the clinician and patient when determining whether one is likely to benefit from these compounds. </strong></p></blockquote><p></p>
[QUOTE="madman, post: 154789, member: 13851"] [B][COLOR=rgb(184, 49, 47)]Abstract:[/COLOR] Nitric oxide (NO) is a well-known vasodilator produced by the vascular endothelium via the enzyme endothelial nitric oxide synthase (eNOS). [COLOR=rgb(184, 49, 47)]The inadequate production of NO has been linked to elevated blood pressure (BP) in both human and animal studies, and might be due to substrate inaccessibility. [/COLOR]This review aimed to investigate whether oral administration of the amino acids l-arginine (Arg) and l-citrulline (Cit), which are potential substrates for eNOS, could effectively reduce BP by increasing NO production. [COLOR=rgb(26, 188, 156)]Both Arg and Cit are effective at increasing plasma Arg. Cit is approximately twice as potent, which is most likely due to a lower first-pass metabolism. The current data suggest that oral Arg supplementation can lower BP by 5.39/2.66 mmHg, which is an effect that is comparable with diet changes and exercise implementation. [/COLOR][COLOR=rgb(44, 130, 201)]The antihypertensive properties of Cit are more questionable, but are likely in the range of 4.1/2.08 to 7.54/3.77 mmHg.[/COLOR] [COLOR=rgb(184, 49, 47)]The exact mechanism by which Cit and Arg exert their effect is not fully understood, as normal plasma Arg concentration greatly exceeds the Michaelis constant (Km) of eNOS. Thus, elevated plasma Arg concentrations would not be expected to increase endogenous NO production significantly, but have nonetheless been observed in other studies. This phenomenon is known as the “l-arginine paradox”. [/COLOR][/B] [COLOR=rgb(184, 49, 47)][/COLOR] [B][COLOR=rgb(184, 49, 47)]5.[/COLOR] Conclusions and Outlook [/B] [B][COLOR=rgb(184, 49, 47)]Endothelium-dependent vasodilation via NO is essential for cardiovascular regulation in normal human physiology. [/COLOR]Dysfunction of the NO pathway occurs via several mechanisms, including substrate unavailability, and has been investigated as a potential pharmacological target. [COLOR=rgb(184, 49, 47)]The administration of NO precursors in the form of Arg have shown promising results with less convincing results for Cit, despite its theoretically advantageous pharmacokinetic properties.[/COLOR][/B] [B]Their ease of administration and sparse adverse effects makes them great candidates in the first-line treatment of borderline or mild hypertension in addition to lifestyle changes, but more research is needed to determine their efficacy and safety as antihypertensive compounds. [/B] [B][COLOR=rgb(184, 49, 47)]Current evidence suggests a BP-lowering effect of Cit and Arg, but more research is needed to solve the “l-arginine paradox” and understand the exact mechanism by which this occurs.[/COLOR][/B] [B]The BP-lowering effect found in the above-presented meta-analyses for both Arg and Cit is based on several small trials with heterogenic study populations regarding baseline BP and comorbidity, in which highly variable intervention durations and dosages were used. More research with larger study populations is needed to confirm these observed effects, establish optimal dosing regiments, and identify possible adverse effects. Furthermore, it would be interesting to identity possible effect modifiers, such as age, gender, comorbidity, and baseline BP, with the latter already demonstrated [49]. This knowledge would be a valuable tool for both the clinician and patient when determining whether one is likely to benefit from these compounds. [/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Nutrition and Supplements
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top